Parisi C - Search Results

1

An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances.

Tateo V, Manuzzi L, Parisi C, De Giglio A, Campana D, Pantaleo MA, Lamberti G. Tateo V, et al. Among authors: parisi c. Pharmaceuticals (Basel). 2021 Apr 1;14(4):316. doi: 10.3390/ph14040316. Pharmaceuticals (Basel). 2021. PMID: 33915954 Free PMC article. Review.

2

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors.

Tateo V, Manuzzi L, De Giglio A, Parisi C, Lamberti G, Campana D, Pantaleo MA. Tateo V, et al. Among authors: parisi c. Int J Mol Sci. 2020 Nov 28;21(23):9056. doi: 10.3390/ijms21239056. Int J Mol Sci. 2020. PMID: 33260538 Free PMC article. Review.

3

Hacking Pancreatic Cancer: Present and Future of Personalized Medicine.

Di Federico A, Tateo V, Parisi C, Formica F, Carloni R, Frega G, Rizzo A, Ricci D, Di Marco M, Palloni A, Brandi G. Di Federico A, et al. Among authors: parisi c. Pharmaceuticals (Basel). 2021 Jul 15;14(7):677. doi: 10.3390/ph14070677. Pharmaceuticals (Basel). 2021. PMID: 34358103 Free PMC article. Review.

4

STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?

Di Federico A, De Giglio A, Parisi C, Gelsomino F. Di Federico A, et al. Among authors: parisi c. Eur J Cancer. 2021 Nov;157:108-113. doi: 10.1016/j.ejca.2021.08.011. Epub 2021 Sep 6. Eur J Cancer. 2021. PMID: 34500370

5

The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers.

Gelsomino F, Lamberti G, Parisi C, Casolari L, Melotti B, Sperandi F, Ardizzoni A. Gelsomino F, et al. Among authors: parisi c. Cancer Treat Rev. 2019 Sep;79:101887. doi: 10.1016/j.ctrv.2019.08.003. Epub 2019 Aug 8. Cancer Treat Rev. 2019. PMID: 31491661 Review.

6

PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy as upfront treatment for advanced NSCLC with PD-L1 expression ≥ 50%: Selecting the best strategy.

Di Federico A, De Giglio A, Parisi C, Gelsomino F, Ardizzoni A. Di Federico A, et al. Among authors: parisi c. Crit Rev Oncol Hematol. 2021 Apr;160:103302. doi: 10.1016/j.critrevonc.2021.103302. Epub 2021 Mar 19. Crit Rev Oncol Hematol. 2021. PMID: 33753247 Review.

7

Programmed Cell Death Protein-1 Inhibitors Versus Programmed Death-Ligand 1 Inhibitors in Addition to Chemotherapy for the First-Line Treatment of Advanced NSCLC: A Systematic Review and Meta-Analysis.

Di Federico A, De Giglio A, Parisi C, Gelsomino F, Boni L, Ardizzoni A. Di Federico A, et al. Among authors: parisi c. JTO Clin Res Rep. 2021 Aug 2;2(9):100214. doi: 10.1016/j.jtocrr.2021.100214. eCollection 2021 Sep. JTO Clin Res Rep. 2021. PMID: 34590054 Free PMC article.

8

Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma.

Lamberti G, Andrini E, Sisi M, Rizzo A, Parisi C, Di Federico A, Gelsomino F, Ardizzoni A. Lamberti G, et al. Among authors: parisi c. Crit Rev Oncol Hematol. 2020 Dec;156:103119. doi: 10.1016/j.critrevonc.2020.103119. Epub 2020 Oct 1. Crit Rev Oncol Hematol. 2020. PMID: 33053439 Review.

9

Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer.

Parisi C, Lamberti G, Zompatori M, Gelsomino F, Salvagni S, Sperandi F, Ardizzoni A. Parisi C, et al. J Immunother Cancer. 2020 Oct;8(2):e000502. doi: 10.1136/jitc-2019-000502. J Immunother Cancer. 2020. PMID: 33004540 Free PMC article.

10

Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study.

Minari R, Mazzaschi G, Bordi P, Gnetti L, Alberti G, Altimari A, Gruppioni E, Sperandi F, Parisi C, Guaitoli G, Bettelli S, Longo L, Bertolini F, Pagano M, Bonelli C, Tagliavini E, Nicoli D, Ubiali A, Zangrandi A, Trubini S, Proietto M, Fiorentino M, Tiseo M; DETECTION Study Group. Minari R, et al. Among authors: parisi c. Clin Lung Cancer. 2020 Sep;21(5):e464-e473. doi: 10.1016/j.cllc.2020.02.021. Epub 2020 Mar 9. Clin Lung Cancer. 2020. PMID: 32276870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page